The emergency department is a pressure cooker where stressed patients, psychological distress and violence combine into a ...

The emergency department is a pressure cooker where stressed patients, psychological distress and violence combine into a ...

Bayer AG’s oral factor XIa inhibitor asundexian significantly reduced ischemic stroke by 26% in patients following a noncardioembolic ischemic stroke or high-risk transient ischemic attack in the ...

Coronation Street has aired a devastating cliffhanger for Debbie Webster tonight, following her dramatic court sentencing.

Global phase 3 OCEANIC-STROKE randomized 12,327 patients to asundexian 50 mg daily vs placebo on background antiplatelets, with follow-up to 31 months. Treatment effects were consistent across TOAST ...

A Marshall County funeral home is facing a lawsuit after a woman alleged they improperly cared for her deceased brother and ...

For patients with noncardioembolic ischemic stroke or high-risk transient ischemic attack, asundexian, a factor XIa inhibitor, reduced risk for secondary stroke with no excess risk for any bleeding vs ...

An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic ...

Doctors know that once someone has had a stroke, the risk of a second one is much higher. In fact, nearly one in four stroke ...

The factor XIa inhibitor asundexian reduced recurrent ischemic stroke without increasing major or minor bleeding in patients ...

A new predictive tool may help identify patients at risk for poststroke dementia, potentially accelerating research and ...

In a U.S. ED observation TIA cohort, transthoracic echocardiography identified high risk cardioembolic features in nearly 1 in 5, most often patent foramen ovale and reduced LVEF.